Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Requires the HHS Secretary to prepare and submit, within 180 days, a strategy for public health preparedness and biodefense addressing risks from misuse of artificial intelligence. The strategy must include a preparedness framework, defined duties and metrics, capability gaps, mitigation strategies (including biological-weapons and treatment-resistant pathogen design), stakeholder consultation, and constrained sharing with congressional committees to protect national security.
Funding: supporters want appropriations; bill includes none
Technocratic, non-controversial mandate with bipartisan appeal; lack of funding and competing priorities could slow floor action.
Requires the HHS Secretary to prepare and submit, within 180 days, a strategy for public health preparedness and biodefense addressing risks from misuse of artificial intelligence.
The strategy must include a preparedness framework, defined duties and metrics, capability gaps, mitigation strategies (including biological-weapons and treatment-resistant pathogen design), stakeholder consultation, and constrained sharing with congressional committees to protect national security.
The bill also amends the Public Health Service Act to explicitly include federal responses covered by this AI strategy.
Content is narrow, technical, and addresses bipartisan concerns about AI and biosecurity, but absence of funding and competing legislative priorities add uncertainty.
How solid the drafting looks.
Funding: supporters want appropriations; bill includes none
These are examples from the analysis, not a ranked list of the most-affected groups.
Funding: supporters want appropriations; bill includes none
Generally supportive of a federal strategy to prevent AI-enabled biological threats and strengthen public health preparedness.
Will want explicit funding, civil liberties protections, transparency, equitable readiness, and strong oversight to prevent mission creep.
Pragmatically supportive as a sensible planning exercise addressing emerging risks from AI.
Wants clear cost estimates, measurable milestones, and careful interagency coordination to avoid duplication and unfunded mandates.
Cautiously supportive because of national security benefits, but wary of expanding federal authority and regulatory burdens on biotech and AI companies.
Will press for limited scope, private-sector protections, and state roles.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrow, technical, and addresses bipartisan concerns about AI and biosecurity, but absence of funding and competing legislative priorities add uncertainty.
The bill has not accumulated any surfaced votes yet.
Funding: supporters want appropriations; bill includes none
Content is narrow, technical, and addresses bipartisan concerns about AI and biosecurity, but absence of funding and competing legislative…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Strategy for Public Health Preparedness and Response to Artifi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.